Claudia Wild, Priv.-Doz. Dr. phil.
Director
Strategy and Management
Head: Evaluation of Medical Procedures, European Cooperation
Phone: +43(0)1-2368119-12
E-mail: claudia.wild[at]aihta.at
Claudia Wild is Chief Executive Officer (CEO) of AIHTA GmbH since 2020. Before she has been Director of the LBI-HTA since its establishment in 2006. From 1989-2006 she worked as a Senior Researcher at the Institute of Technology Assessment at the Austrian Academy of Sciences and helped developing the research field Health Technology Assessment in Austria. Prior to that, she was Research Associate on "media impact on cognitions" at the Institute for Communications and Political Science at the University of Nuernberg/Germany and worked as a freelancer on media impact research projects. She studied communications & psychology at the University of Vienna and political sciences at the Ohio University in Athens/Ohio/USA and completed her studies with a Graduation at the University of Vienna as Doctor of Philosophy in 1985. In 2009, she habilitated in social medicine (Medical University Graz) on the topic of "resource allocation in health-care systems".
Personal Memberships/Council Activities:
Since 2008 Member of the International Advisory Board of ZEFQ (Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen)
Since 2010 Member of the Editorial Board des INT J TAHC/ International Journal for Technology Assessment in Health Care
Since 2010 Member of the Advisory board of "Health Statistics" of Statistic Austria
Since 2011 Member of the National Oncology Advisory Board for developing a national cancer plan
Since 2022 Member of the EC Science and Innovation Panel (SIP) of the Innovative Health Initiative (IHI)
2005 to 2013 Member of Supreme Health Council (advisory committee of the Health Minister)
2007 to 2023 Member of the working group “Public Health” at Transparency International – Austrian Chapter (TI-AT)
2017 to 2019 member of the EC-Expert Panel on “Effective Ways of Investing in Health”
2021 to 2022 Member of EC-Expert Group on COVID-19 Therapeutics
2021 to 2022 Member of Joint Access Advisory Mechanism (JAAM) for covid-19 platform trials
Teaching:
Lecturer in numerous Austrian Master courses at universities and technical colleges on HTA
Reviewing Activities for:
German Journal for Evidence and Quality in Healthcare“ (ZEFQ)
European Journal of Public Health
Health Policy
International Journal of Technology Assessment in Health Care
BMJ
Institutional Memberships International:
HTAi/Health Technology Assessment international
INAHTA/International Network of Health Technology Assessment
Deutsches Netzwerk Evidenzbasierte Medizin (DNEbM)/German Network for EBM
Verein zur Förderung der Technologiebewertung im Gesundheitswesen (Health Technology Assessment)/German Society for promoting HTA
EC-Expert Panel on Effective ways of Investing in Health
Institutional Memberships in Austria:
ÖGPH/Österreichische Gesellschaft für Public Health/Austrian Society for Public Health
